Outlook Therapeutics Announces Formal Dispute Resolution Request Regarding Biologics License Application Accepted By FDA; Final Meeting With Deciding Official To Be Conducted In April

Benzinga Newsdesk www.benzinga.com Neutral 90.0%

Neg 0% Neu 90% Pos 0%

Comments

No comments yet. Be the first!